Jeffrey R. Stewart is Executive Vice President, Chief Commercial Officer. He is responsible for leading the global commercial organization for the enterprise.
Mr. Stewart joined Abbott in 1992 as part of TAP, Abbott’s former U.S. joint venture with Takeda Chemical Industries. Following his time with TAP, Mr. Stewart held various leadership positions in Abbott’s U.S. and international pharmaceutical businesses, including Divisional Vice President, Immunology; Divisional Vice President, Primary Care; General Manager, Virology; and General Manager, United Kingdom. Prior to AbbVie's separation from Abbott in January 2013, Mr. Stewart served as Vice President, Abbott Proprietary Pharmaceutical Division, United States.
Mr. Stewart previously led the U.S. Area for 10 years, including most recently as Senior Vice President, U.S. Commercial Operations.
Mr. Stewart serves on the Board of the European Federation of Pharmaceutical Industries and Associations and previously served on the Boards of the National Pharmaceutical Council and Pharmaceutical Research and Manufacturers of America. At AbbVie, he is the executive chair of the Asian Leadership Network, an Employee Resource Group.